Drug intelligence / Profile preview

Lingguazhuqi Decoction

Development stage: Preclinical
Lead developer: Guangming Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Lingguazhuqi Decoction is a Traditional Chinese Medicine (TCM) formula that has been investigated for its efficacy in treating chronic diarrhea, specifically when associated with spleen insufficiency and phlegm-damp syndrome. It is administered orally and has shown promise in improving symptoms of chronic diarrhea. The specific herbal composition and detailed molecular mechanisms of action are not explicitly provided in the available context.

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)MMP9 (Matrix metalloproteinase-9)STAT1 (Signal transducer and activator of transcription protein 1)CCND1 (Cyclin D1)HIF1A (Hypoxia-inducible factor 1-alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on Lingguazhuqi Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lingguazhuqi Decoction.

Explore the full profile